focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Delisting, Posting of Circular and Notice of AGM

2 Sep 2020 07:00

RNS Number : 7268X
Premier Veterinary Group PLC
02 September 2020
 

 

 

PREMIER VETERINARY GROUP PLC

 

("PVG", the "Company" or the "Group")

 

Delisting Update

Posting of Circular

Notice of General Meeting and Annual General Meeting

 

 

 

 

London, UK, 2 September 2020 - Premier Veterinary Group PLC (LSE: PVG) announces that, further to its announcement on 13 August 2020 (the "Announcement"), the Company has posted a circular to shareholders convening a General Meeting on 24 September 2020 (the "General Meeting") to approve the Resolutions upon which the Acquisition of AHCL is conditional, and provide an update on the date of its delisting.

Capitalised terms and expressions used in this announcement have the meanings given to them in the Announcement.

Posting of Circular

On 13 August 2020, the Company announced that it had entered into the Sale and Purchase Agreement recording the terms of the proposed acquisition by the Company of AHCL, the pet healthcare plan business of the Simplyhealth Group. The Acquisition is conditional upon:

· the passing by Shareholders of the First Whitewash Resolution and certain other resolutions, which it is proposed be put to the General Meeting;

· the receipt of confirmation from the CMA that it does not propose to examine the Acquisition or, where the CMA does commence a review of the Acquisition, the receipt of a decision by the CMA that it does not intend to refer the Acquisition to an in-depth (Phase 2) investigation; and

· the Company cancelling the standard listing of the Ordinary Shares on the Official List and the cancellation of the admission to trading of the Ordinary Shares on the London Stock Exchange's main market for listed securities.

 

A circular has been posted setting out further information regarding the Acquisition, the Simplyhealth Group and containing a notice of the General Meeting at which resolutions necessary to implement the Acquisition and certain other matters will be put to Shareholders. The Circular also contains details of a second Rule 9 whitewash waiver that is required to allow any exercise by the Existing Concert Party of the Existing Warrants, New Warrants and Director Share Options prior to any conversion of the Convertible Loan.

The General Meeting will be held at the Company's offices at First Floor, Uppingham Gate, Uppingham, Rutland LE15 9NY on 24 September 2020 at 10.30 a.m., or so as soon thereafter as the 2020 AGM convened for 10.00 a.m. on that day has concluded.

A copy of the circular (containing the GM notice) and the notice of Annual General Meeting can be found on the Company's website, http://investors.premiervetgroup.co.uk/.

Delisting

In the Announcement, the Company gave notice of its intention to cancel the standard listing of its Ordinary Shares on the Official List and to request the London Stock Exchange to cancel the admission to trading of the Ordinary Shares on the Main Market. It was expected that the last day of dealings in the Ordinary Shares on the Main Market would be 15 September 2020 and that cancellation of the listing of the Ordinary Shares on the Official List would take effect at 8.00 a.m. on 16 September 2020.

The Company has now deferred the effective date of its Delisting until after the General Meeting.

Therefore it is now expected that the last day of dealings in the Ordinary Shares on the Main Market will be 24 September 2020. Cancellation of the listing of the Ordinary Shares on the Official List is expected to take effect at 8.00 a.m. on 25 September 2020.

The Company is currently considering options for implementing an off-market trading facility and expects to make a further announcement in this regard on or before the date of the General Meeting.

 

 

-Ends-

 

For further information, please contact:

Premier Veterinary Group plc

www.premiervetgroup.co.uk

Dominic Tonner, Chief Executive Officer

+44 (0)117 970 4130

Andy Paull, Chief Financial Officer

 

 

 

WH Ireland Limited (Broker)

www.whirelandplc.com

Mike Coe / Chris Savidge

+44 (0) 207 220 1666

 

For further details go to: www.premiervetgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBUGDCXSGDGGB
Date   Source Headline
22nd Apr 20093:34 pmRNSAGM Results
7th Apr 200911:09 amRNSAnnual Information Update
7th Apr 20097:00 amRNSResearch Update
17th Mar 20095:03 pmRNSHolding(s) in Company
13th Mar 20094:25 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSFinal Results
2nd Mar 200911:21 amRNSVoting Rights and Capital
26th Feb 20097:00 amRNSPatent Filing
17th Feb 20092:14 pmRNSHolding(s) in Company
16th Feb 20095:39 pmRNSHolding(s) in Company
16th Feb 20097:00 amRNSResearch Update
5th Feb 200910:50 amRNSDealing by Employee Benefit Trust
2nd Feb 20097:00 amRNSDirector/PDMR Shareholding
21st Jan 20094:40 pmRNSSecond Price Monitoring Extn
21st Jan 20094:37 pmRNSPrice Monitoring Extension
21st Jan 200912:12 pmRNSNotice of Results
14th Jan 20097:00 amRNSRe Agreement
9th Jan 200910:23 amRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrinam Phase III trial to commence
6th Jan 20097:00 amRNSResearch Update
31st Dec 20089:00 amRNSTotal Voting Rights
16th Dec 20083:46 pmRNSNotification of Major Interests in Shares
9th Dec 20084:40 pmRNSSecond Price Monitoring Extn
9th Dec 20084:35 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSRegulatory Approval
5th Dec 20082:28 pmRNSBlocklisting Six Monthly Return
1st Dec 20087:00 amRNSRegulatory Application
24th Nov 200811:58 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSInterim Management Statement
20th Oct 20087:00 amRNSProduct Launch
2nd Oct 20087:00 amRNSArk secures reimbursement for Neuropad
30th Sep 20085:06 pmRNSVoting Rights and Capital
17th Sep 20081:08 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
27th Aug 20087:00 amRNSResearch Update
26th Aug 20084:08 pmRNSHolding(s) in Company
1st Aug 200810:47 amRNSVoting Rights and Captial
31st Jul 20081:12 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSResearch Update
16th Jul 20087:00 amRNSResearch Update
8th Jul 200811:00 amRNSArk opens new manufacturing f
24th Jun 200811:28 amRNSHolding(s) in Company
18th Jun 20087:00 amRNSResearch Update
6th Jun 200812:10 pmRNSBlocklisting Application
3rd Jun 200810:58 amRNSBlocklisting Interim Review
3rd Jun 200810:51 amRNSBlocklisting Interim Review
2nd Jun 20087:00 amRNSRegulatory Approval
30th May 20084:52 pmRNSVoting Rights and Capital
30th May 20087:00 amRNSResearch Update
22nd May 20081:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.